NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.

Journal Article (Journal Article)

The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further investigation, and summarize the NCCN Management of Immunotherapy-Related Toxicities Panel discussions for the 2020 update to the guidelines regarding immune checkpoint inhibitor-related diarrhea/colitis and cardiovascular irAEs.

Full Text

Duke Authors

Cited Authors

  • Thompson, JA; Schneider, BJ; Brahmer, J; Andrews, S; Armand, P; Bhatia, S; Budde, LE; Costa, L; Davies, M; Dunnington, D; Ernstoff, MS; Frigault, M; Kaffenberger, BH; Lunning, M; McGettigan, S; McPherson, J; Mohindra, NA; Naidoo, J; Olszanski, AJ; Oluwole, O; Patel, SP; Pennell, N; Reddy, S; Ryder, M; Santomasso, B; Shofer, S; Sosman, JA; Wang, Y; Weight, RM; Johnson-Chilla, A; Zuccarino-Catania, G; Engh, A

Published Date

  • March 2020

Published In

Volume / Issue

  • 18 / 3

Start / End Page

  • 230 - 241

PubMed ID

  • 32135517

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2020.0012


  • eng

Conference Location

  • United States